The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 12, 2009
Filed:
May. 20, 2005
Motohide Satoh, Osaka, JP;
Takashi Matsuda, Osaka, JP;
Satoshi Okuda, Osaka, JP;
Hiroshi Kawakami, Osaka, JP;
Hisateru Aramaki, Osaka, JP;
Hisashi Shinkai, Osaka, JP;
Yuji Matsuzaki, Osaka, JP;
Wataru Watanabe, Osaka, JP;
Kazunobu Yamataka, Osaka, JP;
Shinichi Kiyonari, Osaka, JP;
Shuichi Wamaki, Osaka, JP;
Mitsuru Takahashi, Osaka, JP;
Naohito Yamada, Osaka, JP;
Akemi Nagao, Osaka, JP;
Motohide Satoh, Osaka, JP;
Takashi Matsuda, Osaka, JP;
Satoshi Okuda, Osaka, JP;
Hiroshi Kawakami, Osaka, JP;
Hisateru Aramaki, Osaka, JP;
Hisashi Shinkai, Osaka, JP;
Yuji Matsuzaki, Osaka, JP;
Wataru Watanabe, Osaka, JP;
Kazunobu Yamataka, Osaka, JP;
Shinichi Kiyonari, Osaka, JP;
Shuichi Wamaki, Osaka, JP;
Mitsuru Takahashi, Osaka, JP;
Naohito Yamada, Osaka, JP;
Akemi Nagao, Osaka, JP;
Japan Tobacco Inc., , JP;
Abstract
Provision of a compound having an anti-HIV activity, particularly an integrase inhibitory activity. A 4-oxoquinoline compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is as defined in the specification. The present invention also relates to a pharmaceutical composition containing the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier; an integrase inhibitor, an antiviral agent, anti-HIV agent, and the like, which contains the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof as an active ingredient; an anti-HIV composition containing the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof, and one or more other kinds of anti-HIV activity substances as active ingredients; an anti-HIV agent containing the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof as an active ingredient, which is used for a multiple drug therapy with other anti-HIV agent(s), and the like.